Bristol Myers Squibb (CELG-RI) Enterprise Value Growth (1y) (2010 - 2026)

Bristol Myers Squibb (CELG-RI) Enterprise Value Growth (1y) (2010 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn
10 Bristol Myers Squibb - - 8.07 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 10.84%
Dec 31, 2025 1.54%
Sep 30, 2025 -104.75%
Jun 30, 2025 -105.32%
Mar 31, 2025 -21.96%
Dec 31, 2024 11.61%
Sep 30, 2024 -5.45%
Jun 30, 2024 23.91%
Mar 31, 2024 -4.40%
Dec 31, 2023 -32.94%
Sep 30, 2023 14.98%
Jun 30, 2023 34.13%
Mar 31, 2023 38.22%
Dec 31, 2022 45.61%
Sep 30, 2022 42.51%
Jun 30, 2022 -2.04%
Mar 31, 2022 -15.87%
Dec 31, 2021 -7.20%
Sep 30, 2021 26.04%
Jun 30, 2021 40.24%